BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 874973)

  • 1. 3-hydroxyisoxazole-5-hydroxamic acid.
    Hines JW; Stammer CH
    J Med Chem; 1977 Jul; 20(7):965-7. PubMed ID: 874973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Carboxamido-4-amino-3-isoxazolidone, and asparagine analogue.
    Stammer CH; Sato M
    J Med Chem; 1978 Jul; 21(7):709-12. PubMed ID: 27638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological properties of derivatives of isoxazolo [5,4-d]-6,7-dihydropyrimidines.
    Machoń Z; Ryng S
    Pol J Pharmacol Pharm; 1988; 40(2):209-16. PubMed ID: 3237570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some hydroxamic acid derivatives of benzimidazole and their antibacterial and antifungal activities.
    Güneş HS; Coşar G
    Arzneimittelforschung; 1992 Aug; 42(8):1045-8. PubMed ID: 1418079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of mono- and bis-hydrazones of cyclic aminoguanidines.
    Sidzhakova D; Panajotova B; Mardirossjan Z; Tabakova S; Maneva L; Marinova V; Golovinsky E
    Pharmazie; 1993 Jun; 48(6):417-9. PubMed ID: 8341729
    [No Abstract]   [Full Text] [Related]  

  • 6. [5-(3-aminopropyl)-isoxazoles: synthesis and antibacterial activity of various derivatives].
    Dannhardt G; Grobe A; Gussmann S; Obergrusberger R; Ziereis K
    Arch Pharm (Weinheim); 1988 Mar; 321(3):163-6. PubMed ID: 3389983
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antifungal activity of novel isoxazolidine compounds.
    Mullen GB; Swift PA; Bennett GA; DeCory TR; Maryniak DM; Dormer PG; St Georgiev V
    Ann N Y Acad Sci; 1988; 544():32-45. PubMed ID: 3214072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthesis and antimicrobial activity of 3-nitroisoxazole derivatives].
    Duranti E; Balsamini C; Scheda P
    Farmaco Sci; 1987 Apr; 42(4):299-306. PubMed ID: 3595840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum(IV) chloride complexes with heterocyclic ligands.
    Massacesi M; Pinna R; Ponticelli G; Puggioni G
    J Inorg Biochem; 1987 Feb; 29(2):95-100. PubMed ID: 3559551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer activity of 5-(propargyloxymethyl)-2-oxazolidinones.
    Fugitt RB; Martinelli LC
    J Pharm Sci; 1973 Jun; 62(6):1013-6. PubMed ID: 4712606
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of 4-quinolylazide derivatives and evaluation of their antitumor and antimicrobial activity.
    Savini L; Massarelli P; Pellerano C
    Farmaco; 1993 Apr; 48(4):515-28. PubMed ID: 8357467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aryl-3-(2-arylvinyl)-2-methylisoxazolium tetrafluoborates as selective antibacterial compounds.
    Dal Piaz V; Ciciani G; Bañez M; Vadillo S; Valle J; Torroba T
    Boll Chim Farm; 1986 Nov; 125(11):384-6. PubMed ID: 3593546
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivatives.
    Bennett GA; Swift PA; Mullen GB; Mitchell JT; Allen SD; Georgiev VS
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):210-2. PubMed ID: 2334463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity.
    van't Riet B; Wampler GL; Elford HL
    J Med Chem; 1979 May; 22(5):589-92. PubMed ID: 458812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some pyrazoline and isoxazolin derivatives as possible fungicides.
    Tiwari N; Dwivedi B; Nizamuddin
    Boll Chim Farm; 1989 Nov; 128(11):332-5. PubMed ID: 2637751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo.
    Martin DG; Hanka LJ; Neil GL
    Cancer Chemother Rep; 1974; 58(6):935-7. PubMed ID: 4217217
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies in potential organo-fluorine antibacterial agents. Part 3: Synthesis and antibacterial activity of some new fluorine containing 2,4,5-trisubstituted isoxazoles.
    Pathak VN; Grover V
    Pharmazie; 1979; 34(9):568-9. PubMed ID: 396535
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
    Jurd L; Narayanan VL; Paull KD
    J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzisoxazolones: antimicrobial and antileukemic activity.
    Wierenga W; Evans BR; Zurenko GE
    J Med Chem; 1984 Sep; 27(9):1212-5. PubMed ID: 6471074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.